Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025
Filed with SSE · · 18 pages · Chinese
Release
Bloomage Biotechnology Corp. Ltd. on 6ix
Earlier from Bloomage Biotechnology
- Announcement on Receiving Commitment Letter on Special Loan for Controlling Shareholder's Share Increase
- Announcement on Voluntary Disclosure of Completion of Medical Device Master File Registration for Sodium Chondroitin Sulfate Produced by Fermentation
- Announcement on Shareholding Increase Plan of Controlling Shareholder
- Announcement on Electing Employee Representative Director of the 3rd Board of Directors
- Announcement on Voluntary Disclosure of Subsidiary Passing On-site Inspection by FDA
Later from Bloomage Biotechnology
- Announcement on the 1st Share Increase by Controlling Shareholder and Progress of the Share Increase Plan
- Announcement on Progress in Shareholding Increase by Controlling Shareholder and Completion of Half of the Planned Increase Amount
- Announcement on Progress in Shareholding Increase by Controlling Shareholder and Amount Exceeding the Lower Limit of the Increase Range
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Indicative Announcement on Progress of Shareholding Increase by Controlling Shareholder and Change in Shareholding Reaching Integer Multiples of 5%
Follow Bloomage Biotechnology into a list and get an email when it puts out news.
Follow Bloomage Biotechnology